Multidrug resistance modifying dithianes

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D33908

Patent

active

053027272

ABSTRACT:
Compounds of the formula ##STR1## wherein R is a residue of the formula ##STR2## and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, X, Y and Z are as described, with the exception of rac-N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-.beta.,N-dimethyl-m -dithiane-2-propanamine, as well as their acid addition salts, in particular for use in eliminating cytostatic resistance in tumor treatment and chloroquine resistance in malaria.

REFERENCES:
patent: 4003914 (1977-01-01), Ramuz
patent: 4073797 (1978-02-01), Ramuz
patent: 4127588 (1978-11-01), Ramuz
Tsuruo et al., Cancer Res. 41:1967-1972 (1981).
Ramuz et al., Eur. J. Med. Chem. 24:493-496 (1989).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Multidrug resistance modifying dithianes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Multidrug resistance modifying dithianes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multidrug resistance modifying dithianes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2099737

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.